Skip to main content

Aravive, Inc.

ARAVDelisted Jan 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001513818

Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Aravive, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of ARAV: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders3635−1
Shares18.4M17.0M−1.39M (−7.5%)
Value$36.9M$21.5M−$15.4M (−41.7%)

New holders (7)

Institutions that held Aravive, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to ARAV in Q2 2023
InstitutionSharesValue% of portfolio
HRT Financial LP127,062$160.0K0.00%
Citadel Advisors LLC107,555$135.5K0.00%
Ergoteles LLC16,123$20.3K0.00%
Collective Family Office LLC15,400$19.4K0.01%
Royal Bank of Canada1,337$1.00K0.00%
FMR LLC18$220.00%
CWM, LLC16$00.00%

Sold out (8)

Institutions that held Aravive, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of ARAV in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Susquehanna International Group, LLP131,635$263.3K
Qube Research & Technologies Ltd53,919$107.8K
Virtu Financial LLC14,242$28.0K
Freedom Wealth Alliance, LLC13,912$27.8K
Squarepoint Ops LLC11,350$22.7K
Point72 Asset Management, L.P.6,378$12.8K
Cubist Systematic Strategies, LLC2,735$5.47K
Point72 Middle East FZE2,601$5.20K